Cómo citar
1.
Alonso Rojas YM. Púrpura de henoch-schönlein. Rev.méd.sinerg. [Internet]. 2 de junio de 2017 [citado 4 de noviembre de 2024];2(6):15-9. Disponible en: https://revistamedicasinergia.com/index.php/rms/article/view/84
Resumen
La púrpura de Henoch-Schönlein (PHS) es un trastorno mediado por la inmunoglobulina A (IgA) aguda. La etiología de la PHS se desconoce, las principales manifestaciones clínicas de PHS son cutáneas, gastrointestinales, articulares y renales. El diagnóstico es clínico, en la mayoría de los pacientes el curso es autolimitado.
Palabras clave
Cardiopatía adquirida. valvular cardiacas. valvula mitral. valvula tricúspide.
Citas
1. M. Huber, J. King, P. McLaine, T. Klassen and M. Pothos. A randomized, placebo-controlled trial of prednisone in early Henoch Schönlein Purpura. BMC Medicine 2004:1.
2. Nickavar, M. Mehrazma, A. Lahouti. Clinicopathologic Correlations in Henoch-Schonlein Nephritis. IJKD 2012;6:437-401.
3. Baselga E, Drolet B, Esterly N. Purpura in infants and children. J Am Acad Dermatol. 1997; 37:673- 705.
4. V. Reamy, P. M. Williams, T. J. Lindsay. Henoch-Schönlein Purpura. American Family Physician 2009; 80:697-704.
5. S. Alfredo, N. A. Nunes, C. A. Len, C. M. Barbosa, M. R. A. Terreri, M. Odete E. Hilário. Henoch- Schönlein purpura: recurrence and chronicity. J Pediatr. 2007; 83:177-180.
6. Chen O, Zhu XB, Ren P, Wang YB, Sun RP, Wei DE. Henoch Schönlein Purpura in children: clinical analysis of 120 cases. African Health Sciences 2013; 13: 94 – 99.
7. B. Nebreda, F. C. Vicente, A. A. Muntañola. Púrpura de Schönlein-Henoch. Piel. 2006; 21:48492.
8. Dolezalova P, Telekesova P, Nemcova D, Hoza J. Incidence of vasculitis in children in the Czech Republic: 2-year prospective epidemiology survey. J Rheumatol 2004; 31:2295–9.
9. E J Tizard, M J J Hamilton-Ayres. Henoch–Schönlein purpura. Arch Dis Child Educ Pract Ed 2008; 93:1–8.
10. EULAR/PRINTO/PRES criteria for Henoch–Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis 2010; 69:798–806.
11. G. D, S. F. Púrpura de Schönlein Henoch. Arch Argent Pediatr. 2001; 99:168-170.
12. H Narchi. Risk of long term renal impairment and duration of follow up recommended for Henoch- Schönlein purpura with normal or minimal urinary findings: a systematic review. Arch Dis Child 2005; 90:916–920.
13. Hugh J. McCarthy & E. Jane Tizard. Clinical practice: Diagnosis and management of Henoch– Schönlein purpura. Eur J Pediatr 2010; 169:643–650
14. Jahed M. Hamdan, Mousa A. Barkawi. Henoch Schönlein Purpura in Children: Influence of age on the incidence of nephritis and arthritis. Saudi Med J 2008; 29:549-552 15. J. Davin. Henoch- Schönlein Purpura Nephritis: Pathophysiology, Treatment, and Future Strategy. Clin J Am Soc Nephrol 2011;6: 679–689.
15. J. Aalberse, K. Dolman, G. Ramnath, R. Rodrigues Pereira, J. Claude Davin. Henoch– Schönlein purpura in children: an epidemiological study among Dutch paediatricians on incidence and diagnostic criteria. Ann Rheum Dis 2007; 66:1648–1650.
16. J. J. de Almeida, L. M. A. Campos, L. B. Paim, C. Leone, V. Hermínia K. Koch, C. Artur A. Silva. Renal involvement in Henoch-Schönlein purpura: a multivariate analysis of initial prognostic factors. J Pediatr (Rio J). 2007;83:259-266.
17. J. Ronkainen, O. Koskimies, M. Ala-Houhala, M. Antikainen, J. Merenmies, J. Rajantie, T. Örmala, J. Turtinen and M. Nuutinen. J Pediatr 2006;149:241-7.
18. L. Ángeles, R. Ballona. Púrpura de Henoch-Schönlein: epidemiología, clínica y seguimiento por cinco años en pacientes hospitalizados en el Instituto Especializado de Salud del Niño, 1995-1999. Folia dermatol. Peru 2007; 18: 111-117.
19. L. Watson, A. R. W. Richardson, R. C. L. Holt, C. A. Jones, M. W. Beresford. Henoch Schonlein Purpura. A 5-Year Review and Proposed Pathway. PLoS ONE 2012; 7: e29512
20. L. B. Gámez González, A. Rodríguez Lozano, F. Rivas Larrauri, M.Yamazaki-Nakashimada. Enfermedad de Kawasaki y púrpura de Henoch-Schönlein: vasculitis frecuentes en una asociación infrecuente. Revista Alergia México 2012; 59:37-40.
21. Masuda M, Nakanishi K, Yoshizawa N, Iijima K y Yoshikawa N. Group A streptococcal antigen in the glomeruli of children with Henoch-Schönlein nephritis. Am J Kidney Dis 2003; 41: 366– 370.
22. Saulsbury FT. Epidemiology of Henoch Schönlein purpura. Cleve Clin J Med 2002; 69 (2): S II87- SII90.
23. Yao-Hsu Yang a, Ya-Hui Chuang b, Li-Chieh Wang a, Hsin-Yi Huang a, M. Eric Gershwin c, Bor- Luen Chiang a. Department of Pediatrics. National Taiwan University Hospital. Autoimmunol Rev 2008; 7 (3): 179-843
24. Weiss PF, Feinstein JA, Luan X, Burnham JM y Feudtner C. Effects of corticosteroid on Henoch- Schönlein purpura: a systematic review. Pediatrics 2007; 120 (5):1079-1087.
25. Zaffanello M, Brugnara M y Franchini M. Therapy for children with Henoch-Schönlein purpura nephritis: a systematic. Sci World J 2007; 7: 20-30
2. Nickavar, M. Mehrazma, A. Lahouti. Clinicopathologic Correlations in Henoch-Schonlein Nephritis. IJKD 2012;6:437-401.
3. Baselga E, Drolet B, Esterly N. Purpura in infants and children. J Am Acad Dermatol. 1997; 37:673- 705.
4. V. Reamy, P. M. Williams, T. J. Lindsay. Henoch-Schönlein Purpura. American Family Physician 2009; 80:697-704.
5. S. Alfredo, N. A. Nunes, C. A. Len, C. M. Barbosa, M. R. A. Terreri, M. Odete E. Hilário. Henoch- Schönlein purpura: recurrence and chronicity. J Pediatr. 2007; 83:177-180.
6. Chen O, Zhu XB, Ren P, Wang YB, Sun RP, Wei DE. Henoch Schönlein Purpura in children: clinical analysis of 120 cases. African Health Sciences 2013; 13: 94 – 99.
7. B. Nebreda, F. C. Vicente, A. A. Muntañola. Púrpura de Schönlein-Henoch. Piel. 2006; 21:48492.
8. Dolezalova P, Telekesova P, Nemcova D, Hoza J. Incidence of vasculitis in children in the Czech Republic: 2-year prospective epidemiology survey. J Rheumatol 2004; 31:2295–9.
9. E J Tizard, M J J Hamilton-Ayres. Henoch–Schönlein purpura. Arch Dis Child Educ Pract Ed 2008; 93:1–8.
10. EULAR/PRINTO/PRES criteria for Henoch–Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis 2010; 69:798–806.
11. G. D, S. F. Púrpura de Schönlein Henoch. Arch Argent Pediatr. 2001; 99:168-170.
12. H Narchi. Risk of long term renal impairment and duration of follow up recommended for Henoch- Schönlein purpura with normal or minimal urinary findings: a systematic review. Arch Dis Child 2005; 90:916–920.
13. Hugh J. McCarthy & E. Jane Tizard. Clinical practice: Diagnosis and management of Henoch– Schönlein purpura. Eur J Pediatr 2010; 169:643–650
14. Jahed M. Hamdan, Mousa A. Barkawi. Henoch Schönlein Purpura in Children: Influence of age on the incidence of nephritis and arthritis. Saudi Med J 2008; 29:549-552 15. J. Davin. Henoch- Schönlein Purpura Nephritis: Pathophysiology, Treatment, and Future Strategy. Clin J Am Soc Nephrol 2011;6: 679–689.
15. J. Aalberse, K. Dolman, G. Ramnath, R. Rodrigues Pereira, J. Claude Davin. Henoch– Schönlein purpura in children: an epidemiological study among Dutch paediatricians on incidence and diagnostic criteria. Ann Rheum Dis 2007; 66:1648–1650.
16. J. J. de Almeida, L. M. A. Campos, L. B. Paim, C. Leone, V. Hermínia K. Koch, C. Artur A. Silva. Renal involvement in Henoch-Schönlein purpura: a multivariate analysis of initial prognostic factors. J Pediatr (Rio J). 2007;83:259-266.
17. J. Ronkainen, O. Koskimies, M. Ala-Houhala, M. Antikainen, J. Merenmies, J. Rajantie, T. Örmala, J. Turtinen and M. Nuutinen. J Pediatr 2006;149:241-7.
18. L. Ángeles, R. Ballona. Púrpura de Henoch-Schönlein: epidemiología, clínica y seguimiento por cinco años en pacientes hospitalizados en el Instituto Especializado de Salud del Niño, 1995-1999. Folia dermatol. Peru 2007; 18: 111-117.
19. L. Watson, A. R. W. Richardson, R. C. L. Holt, C. A. Jones, M. W. Beresford. Henoch Schonlein Purpura. A 5-Year Review and Proposed Pathway. PLoS ONE 2012; 7: e29512
20. L. B. Gámez González, A. Rodríguez Lozano, F. Rivas Larrauri, M.Yamazaki-Nakashimada. Enfermedad de Kawasaki y púrpura de Henoch-Schönlein: vasculitis frecuentes en una asociación infrecuente. Revista Alergia México 2012; 59:37-40.
21. Masuda M, Nakanishi K, Yoshizawa N, Iijima K y Yoshikawa N. Group A streptococcal antigen in the glomeruli of children with Henoch-Schönlein nephritis. Am J Kidney Dis 2003; 41: 366– 370.
22. Saulsbury FT. Epidemiology of Henoch Schönlein purpura. Cleve Clin J Med 2002; 69 (2): S II87- SII90.
23. Yao-Hsu Yang a, Ya-Hui Chuang b, Li-Chieh Wang a, Hsin-Yi Huang a, M. Eric Gershwin c, Bor- Luen Chiang a. Department of Pediatrics. National Taiwan University Hospital. Autoimmunol Rev 2008; 7 (3): 179-843
24. Weiss PF, Feinstein JA, Luan X, Burnham JM y Feudtner C. Effects of corticosteroid on Henoch- Schönlein purpura: a systematic review. Pediatrics 2007; 120 (5):1079-1087.
25. Zaffanello M, Brugnara M y Franchini M. Therapy for children with Henoch-Schönlein purpura nephritis: a systematic. Sci World J 2007; 7: 20-30
Descargas
Los datos de descargas todavía no están disponibles.